Top Trends in Healthcare and OTC 2017: Exploring OTC medication, vitamins, minerals and supplements; functional food and drink; and sports nutrition categories

2017-05-05
Price :
Published : May-2017
No. of Pages : 44

Global consumers are becoming more health-conscious as a reaction to rising obesity levels and lifestyle-related illnesses, such as diabetes, in the modern world. Consumers’ busy lives are a major driver for the healthcare and OTC market as people opt for more convenient, multifunctional, and personalized products that better target their specific needs.

Over-the-counter (OTC) drugs are those sold directly to a consumer without a prescription from a healthcare professional, as compared to prescription drugs, which may be sold only to consumers possessing a valid prescription.

The pressures of modern life are taking their toll on consumers as their increasingly hectic lifestyles, due to work, active social lives and family responsibilities, means that stress is the most concerning health issue globally. As a result, healthcare products that help people become either more energized or focused (at work), or more relaxed (outside of work), will be very appealing to stressed consumers.

The majority of global consumers, 62%, are influenced by how a products health and wellbeing when choosing food products; while 60% are influenced when choosing non-alcoholic drinks.1 This is mainly the result of consumers greater awareness about the importance of a healthy balanced diet to their overall wellbeing. The importance of health and wellness for food and drink products is also due to the high levels of obesity impacting global consumers, particularly in more developed nations, causing concern amongst many individuals.

It has identified following key trends in healthcare and OTC –

  • Multifunctional Products: Time poor consumers increasingly demand more multifunctional medicine, food and drink to effectively combat different symptoms simultaneously.
  • Tailor-Made For Me: Consumers are realizing one size doesn’t always fit all, creating demand for more personalized products that target specific ages, gender, DNA, and usage occasions.
  • Natural Lifestyles: Growing distrust of ¬Ďartificial’ ingredients means consumers are going ¬Ďback to basics’ and seeking more natural healthcare products that promote an all-encompassing holistic lifestyle.
  • Smart Healthcare: Smartphones are set to revolutionize the ways in which consumers monitor their health as people increasingly turn to apps and the “internet of things.”

The report “Top Trends in Healthcare and OTC 2017”, covers key trends to watch within the healthcare and over-the-counter sector, insight analysis, innovation intelligence, and product examples. Moreover, this report helps to understand which audiences are most affected by these trends, learn what the key opportunities, drivers, and inhibitors of the top trends are.

Companies mentioned in this report: Cold-Eeze, UVO, Culturelle, Kuxtal Alimentos Funcionales, Berocca Performance, Dr. Jacob’s, Optrex Night Restore, Thylbert, Vive Organic, Masumax, Nature’s Jeannie.

Scope

  • 66% of global consumers agree that they are more likely to purchase products developed for their lifestyles.
  • 77% of global consumers believe that “natural” claims are nutritious.
  • 19% of global consumers will usually turn first to the internet for health or medical advice compared to 43% who first go to doctors or medical professionals.

Reasons to buy

  • Understand what the top trends are in the healthcare and OTC market.
  • Understand which audiences are most affected by these trends.
  • Learn what the key opportunities, drivers, and inhibitors of the top trends are.
  • See the actions that major brands are taking to get ahead.
Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData
More Reports
Title Price Buy Now

Obesity: Gut Hormone Receptors Retain Commercial Prominence

Obesity: Gut Hormone Receptors Retain Commercial Prominence Summary Obesity is a chronic and potentially fatal disease. The most prevalent metabolic disorder affecting people today, obesity requires multidisciplinary continuing treatment. Despite the market's clinical and regulatory challenges, the obesity pipeline is robust and contains a high level of diversity in both molecule types and molecular targets, which is in line with its multifactorial etiology. The primary concern within the market is the need for medications that adequately address the unmet clinical needs in the overweight and obese population, namely efficacious and safe therapies. This report assesses first-in-class innovation across the obesity pipeline. Scope - The obesity pipeline is robust and contains a high leve......
$6995

Hepatitis B: Competitive Landscape to 2027

Hepatitis B: Competitive Landscape to 2027 Summary Hepatitis B is a viral infection of the liver that can become chronic in young children, especially newborns to mothers with HBV infections, and people with compromised immune systems. Chronic hepatitis B is defined as measurable Hepatitis surface antigen (HBsAg) levels for more than six months after an acute infection. Despite the existence of prophylactic vaccines, hepatitis B remains a global public health threat, with approximately 257 million people worldwide living with chronic HBV infections. Chronic hepatitis B cannot be cured and patients have elevated risks of developing liver cirrhosis and hepatocellular carcinoma (HCC). This report provides an assessment of the pipeline, clinical, and commercial landscape of Hepatitis B. Ov......
$3495

Pediatric Vaccines: Epidemiology Forecast to 2028

Pediatric Vaccines: Epidemiology Forecast to 2028 Summary The administration of a vaccine, referred to as vaccination, elicits an immune response that prevents an individual from developing a specific disease when exposed to the corresponding infectious agent in the future. A successful vaccination results in immunization, where the individual is deemed immune to the disease. Routine immunization programs aim to protect children at an early age, when they are the most vulnerable to disease. Prior to the discovery of vaccines, several infectious diseases claimed the lives of millions of children each year. GlobalData epidemiologists utilized comprehensive, country-specific vaccination rate data from nationally representative public health surveillance systems and databases to arrive at ......
$3995

Parkinson’s Disease and Behavioral Complications: PD Therapies Dominate First-in-Class Pipeline, with Novel Target Classes Demonstrating Potential Disease-Modifying Effects

Parkinson's Disease and Behavioral Complications: PD Therapies Dominate First-in-Class Pipeline, with Novel Target Classes Demonstrating Potential Disease-Modifying Effects Summary Parkinson's disease (PD), a progressive neurological disorder that affects movement control, is associated with considerable quality of life impairments and burden of care, particularly in the advanced disease stages. Cognitive and behavioral complications of PD are common. PD-associated dementia and PD-associated psychosis are both highly prevalent and associated with a large disease burden. There is a pressing unmet need within PD, PD-associated dementia, and PD-associated psychosis for more effective disease-modifying pharmacotherapies. Although current therapies can provide patients with symptomatic relie......
$6995

Colitis Global Clinical Trials Review, H1, 2019

Colitis Global Clinical Trials Review, H1, 2019 Summary GlobalData's clinical trial report, "Colitis Global Clinical Trials Review, H1, 2019" provides an overview of Colitis clinical trials scenario. This report provides top line data relating to the clinical trials on Colitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated fro......
$2500

Degenerative Scoliosis Global Clinical Trials Review, H1, 2019

Degenerative Scoliosis Global Clinical Trials Review, H1, 2019 Summary GlobalData's clinical trial report, "Degenerative Scoliosis Global Clinical Trials Review, H1, 2019" provides an overview of Degenerative Scoliosis clinical trials scenario. This report provides top line data relating to the clinical trials on Degenerative Scoliosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrac......
$2500

Conjunctivitis Global Clinical Trials Review, H1, 2019

Conjunctivitis Global Clinical Trials Review, H1, 2019 Summary GlobalData's clinical trial report, "Conjunctivitis Global Clinical Trials Review, H1, 2019" provides an overview of Conjunctivitis clinical trials scenario. This report provides top line data relating to the clinical trials on Conjunctivitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clin......
$2500

Churg-Strauss Syndrome Global Clinical Trials Review, H1, 2019

Churg-Strauss Syndrome Global Clinical Trials Review, H1, 2019 Summary GlobalData's clinical trial report, "Churg-Strauss Syndrome Global Clinical Trials Review, H1, 2019" provides an overview of Churg-Strauss Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Churg-Strauss Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrac......
$2500

Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2019

Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2019 Summary GlobalData's clinical trial report, "Cutaneous B-Cell Lymphoma Global Clinical Trials Review, H1, 2019" provides an overview of Cutaneous B-Cell Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous B-Cell Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - ......
$2500

Colon Cancer Global Clinical Trials Review, H1, 2019

Colon Cancer Global Clinical Trials Review, H1, 2019 Summary GlobalData's clinical trial report, "Colon Cancer Global Clinical Trials Review, H1, 2019" provides an overview of Colon Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Colon Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical tri......
$2500
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy